The Therapeutic Proteins Outlook To 2007: An analysis of leading products and late-stage pipeline developments

Executive Summary

The management report, ’The Therapeutic Proteins Outlook to 2007: An analysis of leading products and late-stage pipeline developments’ is a timely global market assessment of the ten major therapeutic protein classes. This report provides product forecasts to 2007, and defines the driving forces that will impact the therapeutic proteins market, allowing you to determine how the future competitive landscape will affect your company. The therapeutic proteins market is thriving, generating global sales of $33,340m in 2002, a 24% increase upon 2001 sales of $26,881m. Understand the key growth areas and find out whether interferons will continue to be the major driver of overall growth in the next five years. This report provides a single source of key product and sales analysis, summarizing changing competitive dynamics and developments to the market therapeutic proteins. Use this timely analysis to forecast the future with confidence within this market and benchmark your product strategies by therapeutic class against your key competitors.